Back to Journals » ImmunoTargets and Therapy » Volume 3

Emerging treatments in management of prostate cancer: biomarker validation and endpoints for immunotherapy clinical trial design

Total article views   HTML views PDF downloads Totals
8,406 Dovepress* 8,167+ 1,940 10,107
PubMed Central* 239 80 319
Totals 8,406 2,020 10,426
*Since 17 December 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar